Literature DB >> 14991836

Membrane-associated estrogen receptor and caveolin-1 are present in central nervous system myelin and oligodendrocyte plasma membranes.

Dina N Arvanitis1, Huimin Wang, Richard D Bagshaw, John W Callahan, Joan M Boggs.   

Abstract

The estrogen receptor (ER) is a member of a superfamily of ligand-regulated transcription factors that were thought to localize primarily to the nucleus; however, a membrane-associated ER that can initiate rapid non-genomic cell-signaling events has been identified recently in various cells. The presence of the ER in myelin has not been reported although the nuclear form has been detected in oligodendrocytes. We have shown that an ER with similarities to ERbeta is present in isolated central nervous system (CNS) myelin, the myelin sheath in spinal cord and brain sections, and the oligodendrocyte plasma membrane using two-dimensional (2D) PAGE, mass spectrometry, peptide mass fingerprinting, Western blotting of 1D and 2D gels, and confocal microscopy. Caveolin-1 was also shown to be present in isolated CNS myelin and oligodendrocyte plasma membranes, where it was partially colocalized with ER. After Triton X-100 extraction of myelin, the ER was present in an insoluble low-density glycosphingolipid-enriched fraction and even more in a higher density fraction also containing caveolin and cytoskeletal elements, suggesting that the membrane form of ER may be associated with caveolin or the radial component of myelin. The discovery of the ER in the oligodendrocyte plasma membrane and within the myelin sheath indicates a potential role for estrogen in myelin maintenance or functions. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991836     DOI: 10.1002/jnr.20017

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  23 in total

Review 1.  White matter rafting--membrane microdomains in myelin.

Authors:  Lillian S Debruin; George Harauz
Journal:  Neurochem Res       Date:  2006-09-21       Impact factor: 3.996

Review 2.  Caveolin proteins and estrogen signaling in the brain.

Authors:  Jessie I Luoma; Marissa I Boulware; Paul G Mermelstein
Journal:  Mol Cell Endocrinol       Date:  2008-04-22       Impact factor: 4.102

Review 3.  Caveolin proteins: a molecular insight into disease.

Authors:  Hongli Yin; Tianyi Liu; Ying Zhang; Baofeng Yang
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

4.  GPR30 FORMS AN INTEGRAL PART OF E2-PROTECTIVE PATHWAY IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS.

Authors:  Sheetal Bodhankar; Halina Offner
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2011-12

Review 5.  Environmental Mechanisms of Neurodevelopmental Toxicity.

Authors:  Kylie D Rock; Heather B Patisaul
Journal:  Curr Environ Health Rep       Date:  2018-03

6.  Estrogen Attenuates Local Inflammasome Expression and Activation after Spinal Cord Injury.

Authors:  Adib Zendedel; Fabian Mönnink; Gholamreza Hassanzadeh; Arash Zaminy; Malek Masoud Ansar; Pardes Habib; Alexander Slowik; Markus Kipp; Cordian Beyer
Journal:  Mol Neurobiol       Date:  2017-01-27       Impact factor: 5.590

Review 7.  A glycosynapse in myelin?

Authors:  Joan M Boggs; Huimin Wang; Wen Gao; Dina N Arvanitis; Yanping Gong; Weixian Min
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

8.  Neuroprotective actions of selective estrogen receptor modulators.

Authors:  Lydia L DonCarlos; Iñigo Azcoitia; Luis M Garcia-Segura
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

9.  Rapid estradiol-17beta modulation of opioid actions on the electrical and secretory activity of rat oxytocin neurons in vivo.

Authors:  Colin H Brown; Paula J Brunton; John A Russell
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

10.  17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain.

Authors:  Bettina Gerstner; Joan Lee; Tara M DeSilva; Frances E Jensen; Joseph J Volpe; Paul A Rosenberg
Journal:  J Neurosci Res       Date:  2009-07       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.